Introduction
Biallelic mutations in the FAM161A gene have been reported as a rare cause of autosomal recessive retinitis pigmentosa (RP) in several ethnic populations including Indian, Middle Eastern, North African, and German. [1] [2] [3] The gene is expressed in several tissues including the heart, brain, liver, lung, kidney, and muscle, but expression is particularly elevated in the retina. In the murine retina, FAM161A localises to photoreceptor cells during development, and to the inner segment of photoreceptor cells and outer plexiform layer in the adult retina. FAM161A is a ciliary protein, and thus FAM161A-associated disease can be considered a retinal ciliopathy. 4 FAM161A spans 29 kb of genomic DNA at chromosome 2p15 and comprises seven coding exons. The gene encodes two major isoforms, formed by alternative splicing of exon 4 (exon numbering as per NCBI RefSeq ID NM_001201543.1). The major isoform of the protein is formed of 660 amino acids (NCBI RefSeq ID NM_032180.2), whereas the less common isoform (formed by retention of exon 4; NCBI RefSeq ID NM_001201543.1) comprises 716 amino acids. 2 Both isoforms contain a 277-amino-acid domain (UPF0564) that mediates microtubule association 5 and has been previously identified in at least 15 other human proteins. The UPF0564 domain contains three conserved coiled-coil motifs that, in other proteins, mediate oligomerisation and proteinprotein interactions. The FAM161A protein has been shown to interact with several other proteins (POC1B, SDCCAG8, lebercilin, OFD1, CEP290); mutations within these genes lead to retinal degenerations or multi-system disease. Mutations in POC1B have been associated with cone-rod retinal dystrophy, 5 and mutations in LCA5-which encodes lebercilin-have been associated with Leber's congenital amaurosis. 4 A minority of Bardet-Biedl syndrome cases are caused by mutations in SDCCAG8; this syndrome presents with retinal dystrophy, learning difficulties, renal malformation, obesity, and polydactyly. 4 Joubert syndrome is a multisystem disorder that is characterised by cerebellar malformation and RP; FAM161A was shown to interact with two Joubert syndrome-associated proteins, OFD1 and CEP290, the latter also being associated with Leber's congenital amaurosis. 4 Although it has been shown that FAM161A is required for routing of outer segment proteins, such as opsin and rds/peripherin 2, its precise function remains unclear. 6, 7 We aimed to gain insights into the frequency of FAM161A mutations in patients with RP seen at a single UK centre and to characterise the retinal phenotype in individuals with FAM161A-related disease.
Materials and methods
A total of 120 unrelated patients with a clinical diagnosis of RP and a family history suggestive of autosomal recessive inheritance were recruited. The inclusion criteria were a confirmed diagnosis of RP with neither parent affected by disease; with or without consanguinity and/or other affected siblings. These inclusion criteria will unavoidably include some patients with X-linked or de novo autosomal dominant disease. All study subjects presented to the inherited eye disease clinics of a tertiary referral centre (Moorfields Eye Hospital, London, UK) and had no known molecular diagnosis. All patients had undergone commercial genetic testing of major retinal degeneration loci, including dominant, recessive, and syndromic forms of RP (Manchester Regional Genetic Laboratory Services). At the time of testing, the commercially available panel did not include RP28/FAM161A.
Genomic DNA was isolated from peripheral blood leukocytes under standard conditions. PCR primers (Sigma-Aldrich, Haverhill, UK) were designed to amplify each exon and exon-intron junctions of the major transcript NM032180.2 (sequences available upon request). PCR was performed using GoTaq Colourless Master Mix 2X (6.4 μl, Promega), distilled water (6.4 μl), forward/reverse primer (60 nM each), and 10 ng of DNA. The reaction was denatured at 95°C (10 min), and 35 cycles of amplification (30 s at 95°C, 30 s at 55°C, 45 s at 72°C) were performed, before a final extension step (72°C, 10 min). The PCR products were purified using ExoSAP-IT (USB), before sequencing with BigDye v3.1 (Applied Biosystems, Life Technologies Ltd, Paisley, UK) under standard conditions on an ABI3730 DNA sequencer.
In addition to these 120 subjects, a sibling pair of Pakistani origin (family GC3796) was recruited. The two affected brothers were born to consanguineous parents and have been previously tested using single-nucleotide polymorphism (SNP) chip arrays (GeneChip Human Mapping 50 K Xba Array, Affymetrix) according to the manufacturer's recommendations. The pedigree was consistent with the propagation of a single mutant allele from a recent ancestor such that affected individuals were autozygous for this allele and homozygosity mapping was performed using a custom-made python script interacting with a MySQL database. 8 High-throughput next-generation sequence analysis was subsequently performed to identify the exact disease-causing variant using an Agilent SureSelect capture (Custom Design, enriching for 105 known retinal dystrophy genes) 9 and an ABI SOLiD 5500XL sequencer. Sequence data were mapped with SOLiD Lifescope software (Life Technologies Ltd) with the hg19 human genome as a reference. Variants were called using a combination of the Lifescope software suite and Samtools (http://samtools. sourceforge.net/), and filtered for those SNPs with ≥ 5 × coverage. Using Ensembl V.68, variants were annotated to genes, and functional consequences were determined. Likely disease-associated variants that were identified by this method were confirmed by Sanger sequencing.
Results
Sequencing of the FAM161A gene in 120 subjects with RP revealed individuals of British origin (GC18398, GC19423) harbouring a homozygous variant in the gene (c.1309A4T, p.Arg437*); they were not knowingly related. Homozygosity mapping of an additional family with an affected sibling pair (family GC3796; Pakistani origin) revealed four large regions of homozygosity, including a 29-Mb region on chromosome 2 that encompassed the FAM161A gene (Table 1) . Subsequent high-throughput sequencing of retinal disease-associated genes revealed the same FAM161A mutation (c.1309A4T, p.Arg437*), again in the homozygous state.
Haplotype analysis was performed across the FAM161A coding region for SNPs with minor allele frequency 40.01, in order to ascertain whether c.1309A4T is a founder mutation in the Eurasian population (Table 2 ). This demonstrated that the two individuals of British origin (GC18398 and GC19423) had the same FAM161A haplotype. Given the SNP allele frequencies, it was estimated that the probability of the mutation arising de novo on the same haplotype was 2.1%, and it was thus concluded that this change represents a founder mutation in the European population. The haplotype of the Pakistani sibling pair (GC3796) was, however, different from that observed in the British individuals.
Clinical history of GC18398
Subject GC18398, a 52-year-old white British woman, was diagnosed with RP in her 20s, after reporting problems with her peripheral vision. Since the diagnosis there has been progressive visual fields loss and the development of nyctalopia. Past ophthalmic history included bilateral cataract extraction at the age of 40 years. At the last examination, at the age of 49 years, central visual acuity was relatively well preserved (6/12 each eye), but there was significant limitation of the visual fields (constricted to 10°eccentricity in each eye). Fundoscopy revealed a small amount of retinal pigment migration in the right and left eyes (Figure 1a and b) . Fundus autofluorescence (FAF) imaging revealed an abnormal peripheral retina and a hyperautofluorescent ring around the fovea (Figure 1c and d) . The patient has no siblings and neither parent was affected by disease; there was no history of consanguinity (Figure 1e ).
Clinical history of GC19423
Subject GC17745, a 41-year-old white British woman, was diagnosed with RP at the age of 15 years. The patient has one affected sister, and the parents are first cousins (Figure 2a ). Since adolescence, there has been a progressive loss in peripheral visual field and problems with vision in dim illumination. At the last examination, at the age of 40 years, corrected visual was 6/9 in each eye. There was severe bilateral visual field loss (o5°in each eye). Slit lamp examination showed mild posterior subcapsular lens opactities. Fundal examination revealed extensive retinal pigment migration with more nummular pigment deposits in the peripheral retina (Figure 2b) . FAF imaging showed a perifoveal ring of high density and reduced autofluorescencent signal in the periphery in each eye (Figure 2c and d) . Optical coherence tomography (OCT) showed moderate thinning of the central retina in each eye (Figure 2e and f) .
Clinical history of two individuals from family GC3796
Family GC3796 is a consanguineous Pakistani family, with three affected family members; 2 affected brothers were examined: subject IV.1 and subject IV.2 ( Figure 3a) . Subject IV.1 is a 48-year-old man who was diagnosed with RP at the age of 31 years, but despite this late presentation clinical progression of disease has been relatively fast. He had undergone right cataract surgery at the age of 42 years. At the age of 45 years, visual acuity was 6/36 in both eyes, and at his most recent examination, at the age of 48 years, vision was hand movements bilaterally; there was severe visual field loss (o5°in each eye). Fundoscopy revealed extensive retinal pigment migration and attenuation of the retinal vasculature with optic disc pallor (Figure 3b) . FAF imaging showed loss of peripheral autofluorescence in each eye, with normal fluorescence pattern at the central macula (Figure 3c ). OCT revealed preservation of retinal layers at the fovea, although cystic changes were noted in each eye in the perifoveal region (Figure 3d and e) .
Subject IV.2 is a 46-year-old man who was diagnosed with RP at the age of 26 years and, as with his sibling, clinical progression of disease has been relatively fast. He had undergone bilateral cataract surgery at the age of 45 years. At the age of 41 years, visual acuity was 6/60 in both eyes, and at the most recent examination, at the age of 45 years, vision was reduced to perception of light in both eyes. Fundus examination showed signs of advanced RP (Figure 3f) . FAF imaging and OCT were not performed in this individual. 
The grey shading indicates where individuals GC18398 and GC19423 carried the minor allele in homozygous state.
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Discussion
This study aimed to assess whether mutations in FAM161A caused recessive RP in a cohort of patients from a single UK referral centre, and to characterise the phenotype associated with mutations in this gene. We screened a panel of 120 probands with recessive RP, and two were found to harbour biallelic FAM161A variants. This panel was enriched for rare causes of RP, as it comprised patients in whom previous molecular genetic testing had been negative. Our results are not dissimilar to findings from previous studies in North American and German populations in which FAM161A mutations accounted for~1% of recessive RP cases. 4, 10 Notably, a higher disease frequency has been described in the Israeli and Palestinian populations. 3 In our study, three unrelated families harbouring the same FAM161A nonsense mutation (c.1309A4T, p. Arg437*) in the homozygous state were identified. Two of the families carrying the mutation were of British origin, with the remaining family originating from Pakistan. The same mutation (c.1309A4T, p.Arg437*) has been previously reported in a homozygous state in three apparently unrelated German individuals with FAM161A-related disease. 4 Affected members of the two British families (GC18398 and GC19423) had an identical haplotype across the entire coding region of FAM161A, and it is likely that the mutation is a founder mutation in the British population. The haplotype of the British patients was, however, different from that of three seemingly unrelated German patients who carried the same mutation (but who shared the same intragenic haplotype to each other). 4 It seems, then, that the mutation has arisen de novo in two distinct European populations. Furthermore, the same mutation was observed in family GC3796, who are of Pakistani origin and carried a different haplotype. It seems likely, therefore, that the c.1309A4T change occurs at a mutation hotspot, therefore arising de novo in distinct, unrelated populations.
We have not excluded the possibility that any of these individuals carry this mutation in the hemizygous state-with a complete deletion of one copy of FAM161A on the second chromosome. The region surrounding FAM161A on chromosome 2 is rich in short interspersed elements, such as Alu repeats, which can cause a deletion of large genomic regions through the process of nonallelic homologous recombination.
All four FAM161A-positive individuals had identical mutations, but there were some differences in the clinical findings. Subjects GC19423 and GC18398 had typical teenage-onset RP with minimal retinal pigmentation and a hyperautofluorescent ring on FAF imaging. The two individuals from family GC3796 had adult-onset disease but with surprisingly rapid deterioration. There was no hyperautofluorescent ring on FAF imaging in one of the two siblings who was available for testing. OCT demonstrated some preservation of foveal architecure in the right eye (d) and left eye (not shown); a few areas consistent with macular oedema can be observed in the right eye (e) and also in the left eye (not shown). Fundoscopic appearances of individual IV.2 were similar to that of IV.1, with extensive peripheral pigment deposition, pallor of the optic disc, and attenuation of the retinal vessels (f); symmetrical changes were observed in the left eye (not shown).
